AFYX Therapeutics

OverviewSuggest Edit

AFYX Therapeutics (formerly known as Dermtreat ApS) is a biopharmaceutical company focused on innovative approaches to treat mucosal diseases. Its Rivelin patch is designed to deliver a pharmaceutical drug uni-directionally to a mucosal surface using an occlusive, bio-adhesive and bio-degradable patch, with a long adhesion time and high flexibility, conforming to the mucosal surface.

TypePrivate
Founded2014
HQKøbenhavn, DK
Websiteafyxtx.com

Latest Updates

Employees (est.) (Sept 2021)9(-10%)
Cybersecurity ratingAMore

Key People/Management at AFYX Therapeutics

Nishan de Silva

Nishan de Silva

Chief Executive Officer and Director
Lars Siim Madsen

Lars Siim Madsen

Chief Operating Officer
Kristine Peterson

Kristine Peterson

Director
Show more

AFYX Therapeutics Office Locations

AFYX Therapeutics has offices in København and San Diego
København, DK (HQ)
Lergravsvej 57, 2 . tv
San Diego, CA, US
12707 High Bluff Dr Suite 200
Show all (2)

AFYX Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2014

AFYX Therapeutics total Funding

$32.2 m

AFYX Therapeutics latest funding size

$13 m

Time since last funding

2 years ago

AFYX Therapeutics investors

AFYX Therapeutics's latest funding round in June 2019 was reported to be $13 m. In total, AFYX Therapeutics has raised $32.2 m
Show all financial metrics

AFYX Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

AFYX Therapeutics Online and Social Media Presence

Embed Graph

AFYX Therapeutics News and Updates

AFYX Therapeutics Presents Results from Rivelin Clinical Proof of Concept Study in Patients with Vulvar Lichen Sclerosus at the 2019 European Academy of Dermatology and Venereology Congress

SAN DIEGO and COPENHAGEN, Denmark, Oct. 9, 2019 /PRNewswire/ -- AFYX Therapeutics, a clinical stage biopharmaceutical company developing innovative approaches to treat mucosal diseases, today announced results from a Phase 1 clinical proof of concept study evaluating the use of the...

AFYX Therapeutics Frequently Asked Questions

  • When was AFYX Therapeutics founded?

    AFYX Therapeutics was founded in 2014.

  • Who are AFYX Therapeutics key executives?

    AFYX Therapeutics's key executives are Nishan de Silva, Lars Siim Madsen and Kristine Peterson.

  • How many employees does AFYX Therapeutics have?

    AFYX Therapeutics has 9 employees.

  • Who are AFYX Therapeutics competitors?

    Competitors of AFYX Therapeutics include Kartos Therapeutics, Fysius Rugexperts and Right To Care.

  • Where is AFYX Therapeutics headquarters?

    AFYX Therapeutics headquarters is located at Lergravsvej 57, 2 . tv, København.

  • Where are AFYX Therapeutics offices?

    AFYX Therapeutics has offices in København and San Diego.

  • How many offices does AFYX Therapeutics have?

    AFYX Therapeutics has 2 offices.